Bard Financial Services Inc. Has $2.66 Million Holdings in Roche Holding AG (OTCMKTS:RHHBY)

Bard Financial Services Inc. boosted its holdings in Roche Holding AG (OTCMKTS:RHHBY) by 112.1% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 66,500 shares of the company’s stock after purchasing an additional 35,150 shares during the quarter. Bard Financial Services Inc.’s holdings in Roche were worth $2,657,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. SVB Wealth LLC increased its holdings in Roche by 2.6% during the first quarter. SVB Wealth LLC now owns 16,646 shares of the company’s stock worth $531,000 after buying an additional 426 shares during the last quarter. Confluence Investment Management LLC boosted its position in shares of Roche by 3.7% in the second quarter. Confluence Investment Management LLC now owns 12,922 shares of the company’s stock valued at $448,000 after acquiring an additional 459 shares during the period. Norman Fields Gottscho Capital Management LLC boosted its position in shares of Roche by 2.3% in the second quarter. Norman Fields Gottscho Capital Management LLC now owns 24,650 shares of the company’s stock valued at $858,000 after acquiring an additional 550 shares during the period. Archer Investment Corp lifted its position in Roche by 10.6% during the second quarter. Archer Investment Corp now owns 6,810 shares of the company’s stock valued at $236,000 after purchasing an additional 652 shares during the last quarter. Finally, Hancock Whitney Corp raised its stake in shares of Roche by 2.4% during the first quarter. Hancock Whitney Corp now owns 28,995 shares of the company’s stock worth $926,000 after acquiring an additional 678 shares in the last quarter.

Roche Price Performance

RHHBY traded down $0.51 during trading on Friday, reaching $37.77. 1,668,961 shares of the stock were exchanged, compared to its average volume of 2,244,343. Roche Holding AG has a 1 year low of $29.20 and a 1 year high of $42.43. The business’s 50 day moving average price is $40.21 and its two-hundred day moving average price is $35.45. The company has a quick ratio of 1.04, a current ratio of 1.35 and a debt-to-equity ratio of 0.75.

Analyst Ratings Changes

Several equities research analysts have weighed in on the company. Bank of America raised Roche from a “neutral” rating to a “buy” rating in a report on Friday, September 13th. Deutsche Bank Aktiengesellschaft cut Roche from a “hold” rating to a “sell” rating in a report on Friday, September 13th. Three research analysts have rated the stock with a sell rating, one has assigned a hold rating and one has given a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold”.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.